MECHANISMS
A network of vascular mechanisms
Sulodexide is best investigated as a vascular-interface modulator rather than reduced to one pharmacological label. Ten interacting research areas make up the map — every node is a link to its explanation.
- Antithrombin III
The fast-moving heparin-like fraction shows affinity for antithrombin III, the endogenous serine-protease inhibitor that regulates coagulation proteases. This is the classical pharmacology of the principal fraction.
- Heparin cofactor II
Dermatan sulfate interacts with heparin cofactor II, a second endogenous serine-protease inhibitor. The two fractions therefore engage two different endogenous anticoagulant systems.
- Thrombin regulation
Through both cofactor pathways, sulodexide participates in thrombin regulation. Regulation is the accurate word: published pharmacology does not describe clotting being completely disabled.
- Fibrinolytic balance
Profibrinolytic properties have been described in the literature, involving the balance of fibrin formation and clearance. Sulodexide must never be portrayed as instantly dissolving established clots.
- Endothelial glycocalyx
Human mechanistic research reported changes in measured glycocalyx dimensions; experimental work reports permeability improvements via glycocalyx remodelling. Evidence exists alongside continuing uncertainty about mechanism, magnitude and clinical meaning.
- Nitric oxide
Isolated vascular-tissue experiments showed endothelium-dependent, nitric-oxide-mediated relaxation. These are vascular-tissue experiments — not proof of a clinical blood-pressure treatment.
- Inflammatory signalling
Endothelial inflammatory signalling intersects with glycocalyx state, permeability and coagulation. Biomarker studies — including convalescent COVID-19 research — measured inflammatory mediators among their endpoints.
- Vascular permeability
Barrier behaviour is a recurring endpoint: transcapillary albumin escape in human mechanistic work, and permeability assays in cell and animal models. Preclinical findings do not translate automatically into human efficacy.
- Matrix metalloproteinases
MMP-2 and MMP-9 participate in extracellular-matrix turnover and venous pathology. Sulodexide research has touched matrix-remodelling pathways relevant to chronic venous disease.
- Extracellular matrix
The extracellular matrix is the structural context in which the endothelium lives. Matrix biology connects sulodexide research to tissue mechanics, remodelling and the wider vascular-repair question.